China SXT Pharmaceuticals, Inc. (SXTC) Insider Trading Disclosures
China SXT Pharmaceuticals, Inc. (SXTC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SXTC
CIK: 1723980
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 03/31
State: D8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
ENROME LLP
Auditor SinceSince 3/31/2025 12:00:00 AM
Lead Engagement PartnerSing Hong Tan
Audit LocationSingapore, Singapore
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-15 | — | SCHEDULE 13G Filing | 0001493152-26-047269 | View SEC Doc Filr Page |
| 6-K | 2026-10-09 | 2026-10-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-108557 | View SEC Doc Filr Page |
| 424B5 | 2026-10-09 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-108254 | View SEC Doc Filr Page |
| 6-K | 2026-10-08 | 2026-10-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-107829 | View SEC Doc Filr Page |
| 6-K | 2026-10-08 | 2026-10-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-107719 | View SEC Doc Filr Page |
| EFFECT | 2026-09-16 | — | EFFECT Filing | 9999999995-26-002978 | View SEC Doc Filr Page |
| F-3/A | 2026-08-28 | — | AMENDMENT NO. 1 TO FORM F-3 | 0001213900-26-095149 | View SEC Doc Filr Page |
| 6-K | 2026-08-28 | 2026-08-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-095147 | View SEC Doc Filr Page |
| 6-K | 2026-07-24 | 2026-07-24 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-081405 | View SEC Doc Filr Page |
| 424B5 | 2026-07-24 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-081135 | View SEC Doc Filr Page |
| F-3 | 2026-07-07 | — | REGISTRATION STATEMENT | 0001213900-26-075977 | View SEC Doc Filr Page |
| 6-K | 2026-07-06 | 2026-07-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-075528 | View SEC Doc Filr Page |
| 20-F | 2026-07-01 | 2026-03-31 | ANNUAL REPORT | 0001213900-26-074310 | View SEC Doc Filr Page |
| 6-K | 2026-06-01 | 2026-06-01 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-063591 | View SEC Doc Filr Page |
| 424B5 | 2026-06-01 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-063590 | View SEC Doc Filr Page |
| 6-K | 2026-05-04 | 2026-05-04 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-051679 | View SEC Doc Filr Page |
| 3 | 2026-04-27 | 2022-01-31 | 3 Filing | 0001213900-26-048007 | View SEC Doc Filr Page |
| 3 | 2026-04-27 | 2017-07-04 | 3 Filing | 0001213900-26-048006 | View SEC Doc Filr Page |
| 3 | 2026-04-27 | 2025-01-20 | 3 Filing | 0001213900-26-048005 | View SEC Doc Filr Page |
| 3 | 2026-04-27 | 2021-05-22 | 3 Filing | 0001213900-26-048003 | View SEC Doc Filr Page |
| 3 | 2026-04-27 | 2022-05-10 | 3 Filing | 0001213900-26-048001 | View SEC Doc Filr Page |
| 3 | 2026-04-27 | 2025-01-20 | 3 Filing | 0001213900-26-048000 | View SEC Doc Filr Page |
| 3 | 2026-04-27 | 2018-12-31 | 3 Filing | 0001213900-26-047998 | View SEC Doc Filr Page |
| 424B5 | 2026-04-09 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-041766 | View SEC Doc Filr Page |
| 6-K | 2026-04-09 | 2026-04-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-041765 | View SEC Doc Filr Page |